Precision BioSciences, Inc.
DTIL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $65,236 | $46,395 | $4,432,315 | $26,034 |
| - Cash | $44,870 | $62,242 | $77,223 | $85,899 |
| + Debt | $1,458 | $29,445 | $29,748 | $30,045 |
| Enterprise Value | $21,824 | $13,598 | $4,384,840 | -$29,820 |
| Revenue | $13 | $18 | $29 | $638 |
| % Growth | -27.8% | -37.9% | -95.5% | – |
| Gross Profit | -$661 | -$678 | $29 | $638 |
| % Margin | -5,084.6% | -3,766.7% | 100% | 100% |
| EBITDA | -$20,736 | -$22,466 | -$19,506 | -$16,596 |
| % Margin | -159,507.7% | -124,811.1% | -67,262.1% | -2,601.3% |
| Net Income | -$21,772 | -$23,520 | -$20,565 | -$17,745 |
| % Margin | -167,476.9% | -130,666.7% | -70,913.8% | -2,781.3% |
| EPS Diluted | -1.842 | -2.13 | -2.29 | -2.5 |
| % Growth | 13.5% | 7% | 8.4% | – |
| Operating Cash Flow | -$15,270 | -$20,271 | -$19,052 | -$18,683 |
| Capital Expenditures | $0 | -$2 | -$314 | -$97 |
| Free Cash Flow | -$15,270 | -$20,273 | -$19,366 | -$18,780 |